ArticleRespiratory medicine case reports2026
Management of refractory status asthmaticus with sevoflurane in the intensive care unit: Case reports.
Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Status asthmaticus represents a severe asthma exacerbation requiring prompt medical attention and often necessitating intensive care. These case reports describe two adult patients with refractory status asthmaticus who required advanced interventions, including invasive mechanical ventilation and sevoflurane administration due to persistent bronchospasm despite standard therapies. The first case involves a 66-year-old female with a history of asthma and type 2 diabetes who developed bronchospasm following elective cataract surgery, leading to respiratory failure and cardiac arrest. The second case concerns a 26-year-old female with poorly controlled allergic eosinophilic asthma, exacerbated by non-adherence to treatment and environmental exposures, resulting in near-fatal respiratory distress. In both instances, sevoflurane was employed for its bronchodilatory effects via calcium channel inhibition and modulation of inflammatory responses, leading to improved bronchospasm and successful weaning from mechanical ventilation. Ventilatory strategies emphasized low respiratory rates and extended I:E ratios to prevent air trapping and dynamic hyperinflation. Spontaneous breathing trials with zero PEEP facilitated extubation, followed by high-flow nasal cannula support in the first case. Both patients stabilized and were discharged from the ICU. These cases highlight the challenges in managing refractory asthma exacerbations, particularly in perioperative and non-adherent contexts, and underscore sevoflurane's potential as a rescue therapy when conventional treatments fail. They emphasize the importance of vigilant monitoring, timely escalation of care, and tailored ventilatory management to optimize outcomes in status asthmaticus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.